Intra-Cellular, Takeda deal

Intra-Cellular and Takeda partnered to develop and commercialize Intra-Cellular's preclinical phosphodiesterase-1 (PDE-1) inhibitors. The lead compound, which is part of Intra-Cellular's ITI-002 pro...